Articles

Late-stage development is where timelines tighten, complexity increases, and the demand for speed becomes most visible. Execution is often treated as the lever—compressed timelines, parallel workstreams, faster decision-making. But speed is rarely created at that stage. It is shaped earlier,...

Why Field Execution Must Evolve Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and institutional decision-makers (collectively, "customers") — is a major contributor to commercial success. Accordingly, over the...

A blister pack may seem like a simple enough concept until you’re trying to prove that it will open cleanly every time. Peel testing turns each peel into data so you can protect dose integrity, support and child resistance...

The protection of patient health starts with ensuring the safety of pharmaceutical products even before they reach healthcare providers. Every recall caused by defective or leaking containers is one too many. As the pharmaceutical industry continues to evolve towards...

Modern drug development necessitates a shift from fragmented data silos to a unified, intelligence-driven framework. Achieving global regulatory alignment requires a sophisticated approach to trial documentation standards and pharmaceutical regulatory governance, ensuring that clinical trial design remains robust across multiple jurisdictions. By leveraging standardized drug intelligence, sponsors can enhance submission readiness and maintain cross-border compliance, ultimately accelerating the delivery of life-saving therapies to patients worldwide.

Whether professionals need a high-performance gas chromatography system or a mass spectrometer, knowing where to look can help them stay under budget. The best sources for affordable lab equipment are used equipment dealers with online marketplaces. The Vetting Process for...

Vial fill-finish operations are changing faster than ever. New regulations such as the revised Annex 1 demand higher automation and less manual intervention, while new products – from large-scale vaccines to small-batch biologics – require significantly more flexible filling...